Filing Details

Accession Number:
0001181431-12-032118
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2012-05-23 18:50:06
Reporting Period:
2012-05-17
Filing Date:
2012-05-23
Accepted Time:
2012-05-23 18:50:06
Original Submission Date:
2012-05-21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1407038 Bg Medicine Inc. BGMD Services-Medical Laboratories (8071) 043506204
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1443340 Stephane Bancel C/O Bg Medicine, Inc.
610 Lincoln Street North
Waltham MA 02451
Executive Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-05-17 5,008 $3.84 21,786 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.80 to $3.85, inclusive. The reporting person undertakes to provide to BG Medicine, Inc., any security holder of BG Medicine, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote(1) to this Form 4.